|
Below,
Dr. Angela Christiano of Columbia University and Dr. Animesh
Sinha of Weill Cornell Medical College, discuss how genetics
will one day help us keep our coifs.
Q: What is the current state of the
art in hair transplantation?
ANIMESH SINHA, MD, PhD: There have been tremendous advances in
hair transplantation surgery over the last couple decades. You
may remember the old-fashioned plugs that were the horror
stories from two or three decades ago...well the science and the
surgical techniques have evolved into single-graft transplants
and micrografts that have allowed for much more natural
redefinition of the hairline.
Q: Could you explain how cloning
technology might work for hair?
ANGELA CHRISTIANO, PhD: The theory of hair follicle cloning
involves taking a few hair follicle cells from your own scalp --
usually in the back -- or a donor area, and growing or
cultivating large populations of your own cells in a laboratory,
and then surgically reimplanting those cells into the scalp at
the front of the head.
We're not talking about trying to recreate a whole person
from a single hair follicle, so the challenge isn't nearly as
great as it was to make an entire organism from one cell. What
we want to be able to do is use your body's own cells to
regenerate structures that have begun to atrophy or die. The
technology is being widely applied in many areas of medicine,
and involves trying to get your body to do what it knows how to
do, but for some reason cannot anymore.
Q: Are you actually growing hair in
the lab? Or just cells?
ANGELA CHRISTIANO, PhD: One of the great limitations of hair
biology is that we don't yet know how to grow a hair in a dish,
and if we did we'd be in a lot better shape. Right now we have
no good way to do that, so what we're really just hoping to do
is to culture the important cells-the germinative cells-and then
reimplant those into the scalp, and then to let nature take its
course, to basically allow those cells to induce a brand-new
hair follicle.
Q: Has this been done?
ANGELA CHRISTIANO, PhD: In theory, it's already been done. Last
year, a paper was published in Nature which showed that between
a different donor and a different recipient, those particular
cells could be implanted in the forearm of the recipient, and
even in an area where no hair usually grows, those cells were
powerful enough to induce a new hair follicle. No one has
successfully done it on a large scale. If you use your own
cells, of course the hair should be the same color, but there's
the question of growth direction, and the most important
question with the new hair is actually cycle-or whether or not
it will have the ability to grow back once it's fallen out.
Q: How new is this technology?
ANGELA CHRISTIANO, PhD: The field of tissue engineering is just
coming into its own, and the technology to grow cells and
propagate them, to keep them alive in the lab, is relatively
new. More important about these particular types of cells is
keeping them in what we call a primitive state. We don't want
them to differentiate or grow up into mature skin or hair cells.
We want to keep them immature, because we think that in their
immature state is when they have the instructions that dictate
how to make a hair, so the laboratory techniques are just coming
of age. In addition, the surgical techniques for learning how to
reimplant cells in a given direction in a uniform way is
something that will bring us back to the clinic. Eventually, it
will be medical practitioners who probably implant these cells
into recipient patients. With current technology, hair is simply
taken from the back of your head and moved to the front of your
head, so you're working with a finite number of hair follicles.
The beauty of cloning is that you could actually increase the
overall number of follicles, because you wouldn't need to
harvest too many from the back, yet you could build more in the
areas where you need hair.
Q: Is it necessary to use your own
hair follicles, or could you use hair follicles from somebody
else?
ANGELA CHRISTIANO, PhD: One of the nicest things about male
pattern hair loss is that the area in the back of the head, the
fringe, is preserved. In most cases, it's actually protected
from male pattern baldness for reasons we don't understand. One
of the most important lessons from hair transplantation has been
the concept of donor dominance. That is, when you move good
hairs from the back of the head to the front, they maintain the
character from the back of the head and they don't usually fall
out once you move them to the front. So I think the concept of
using a different donor is probably not even necessary, although
the experiment that was published last year was between a male
and a female, very different donors and recipients.
Q: In that case, when the donor and
recipients are different individuals, is there a risk or a
problem with rejection?
ANGELA CHRISTIANO, PhD: In this particular case, the donor and
recipient were not immunologically matched. They had been tested
and they weren't compatible. In the first three hairs that were
grown, there was no evidence for an overt immune response, so it
didn't seem as though the body was rejecting the new hair.
ANIMESH SINHA, MD, PhD: That might open up a whole new
source, a bigger source of potential donors, and you might even
have designer choices of color and texture.
Q: Are there any obstacles that are
in front of you as you go down this cloning road?
ANGELA CHRISTIANO, PhD: Sure. I think right now the biggest
obstacle is learning how to keep the cells alive, and then once
you put them back in, getting them to make new hair. So the
technical aspects are still being worked out, but in theory I
think it's certainly approachable. It's something we might see
sooner than we see a cure for male pattern hair loss.
Q: Can you give us a time estimate?
ANGELA CHRISTIANO, PhD: Right now, the answer is: not within the
next few years. It certainly needs to be perfected and then has
to go through clinical trials to be sure that it's safe, because
it is tissue manipulation, so I think a conservative guess would
be that within five years we might be at the point of clinical
trials, and then perhaps within ten years it will be a
commonplace surgical procedure. But, again, that's the best-case
scenario. |